Cisplatin prescribing information
WebCarboplatin, like cisplatin, produces predominantly interstrand DNA cross-links rather than DNA-protein cross-links. This effect is apparently cell-cycle nonspecific. ... your physician and pharmacist have the complete prescribing information upon which this information is based. You may want to read it and discuss it with your doctor. Remember ... WebSep 1, 2024 · Refer to cisplatin prescribing information for additional information. Pediatric Use The safety and effectiveness of Pedmark have been established to reduce the risk of ototoxicity associated with …
Cisplatin prescribing information
Did you know?
WebSee full prescribing information for complete boxed warning. Nephrotoxicity: cisplatin for injection can cause severe renal toxicity, including acute renal failure. Ensure adequate … WebJun 23, 2024 · Print SmPC information 1. Name of the medicinal product 2. Qualitative and quantitative composition 3. Pharmaceutical form 4. Clinical particulars 5. Pharmacological properties 6. Pharmaceutical particulars 7. Marketing authorisation holder 8. Marketing authorisation number (s) 9. Date of first authorisation/renewal of the authorisation 10.
WebHIGHLIGHTS OF PRESCRIBING INFORMATION • ... Docetaxel Injection in combination with cisplatin and fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). 2. DOSAGE AND ADMINISTRATION WebHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GEMCITABINE INJECTIONsafely and effectively. See full prescribing ... Gemcitabine Injection in combination with cisplatin is indicated for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB) or ...
WebFeb 1, 2024 · The recommended dose of Pemetrexed for injection when administered with cisplatin in patients with a creatinine clearance (calculated by Cockcroft-Gault equation) of 45 mL/min or greater is 500 … WebSep 27, 2024 · See full prescribing information for CISPLATIN INJECTION. CISPLATIN for injection, for intravenous use Initial U.S. Approval: 1978 WARNING: …
WebForHYCAMTIN for injection in combination with cisplatin, reduce the dose to 0.6 mg/m2/day(and further to 0.45 mg/m2 if necessary) for: febrile neutropenia (defined as neutrophil counts less than 1,000/mm3 with temperature of greater than or equal to 38.0 C (100.4 F) or administer G-CSF startingno sooner than 24 hours following the last dose
litho supplies limitedWebApr 3, 2024 · On April 3, 2024, the Food and Drug Administration granted accelerated approval to enfortumab vedotin-ejfv (Padcev, Astellas Pharma) with pembrolizumab (Keytruda, Merck) for patients with locally... litho supplies rochesterWebBefore sharing sensitive information, make sure you're on a federal government site. ... Efficacy for patients ineligible for cisplatin-containing chemotherapy was evaluated in Cohort 2 of EV-201 ... lithos什么意思WebSee full prescribing information for complete boxed warning . • Treatment-related mortality increases with abnormal liver function, at higher doses, and in patients withNSCLC and prior platinum -based therapy receiving docetaxel at 100 mg/m2 (5.1) ... and with cisplatin for litho supplies irelandWebCisplatin Injection is indicated as a single agent for patients with transitional cell bladder cancer which is no longer amenable to local treatments, such as surgery … litho supplies livingstonWebSee full prescribing information for CISPLATIN INJECTION. CISPLATIN for injection, for intravenous use Initial U.S. Approval: 1978 WARNING: NEPHROTOXICITY, PERIPHERAL NEUROPATHY, NAUSEA AND VOMITING, and MYELOSUPPRESSION See full prescribing information for complete boxed warning. lithos vs petrosWebCisplatin injection is indicated as a single agent for patients with transitional cell bladder cancer which is no longer amenable to local treatments, such as surgery and/or … lithotabs